FlexChar

Digital · Origine US / UK

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

Fonte: Marina Temkin · Pubblicato 23 set 2026, 21:31

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

In Digital, Marina Temkin mette questa storia al centro della giornata: The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s. FlexChar la segnala perché sta concentrando ricerche e conversazione.

Brief editoriale FlexChar. L’articolo completo è della fonte.

Leggi la fonte originale

Blog

Potrebbe interessarti

Altro in Digital